In this study, we have developed an in vitro cell expansion method to generate Th1-like cells from naive CD4+ Th cells, and demonstrated their ability to produce multiple Th1-cytokines, cytotoxicity and enhance CD8+ CTL-mediated tumor rejection. Here, CD8A is linked to neoplasm.